Weeks 1-8 (highest risk period): GI side effects are at their peak during initial dose escalation
The medication mimics a naturally occurring hormone (GLP-1) that regulates appetite and blood sugar levels, helping you feel full longer and reducing cravings
Exceptional Access Program (EAP) The EAP facilitates access to drugs not funded through the ODB Formulary, or where no listed alternative is available

Compounded Oral Semaglutide Prescribed Online Personalized Weight Management Start with a free, no-obligation evaluation only pay if treatment is right for you If prescribed, your subscription includes: Personalized Treatment Plans Medication and Supplies Shipping to Your Door Purchase Options Compounded Oral Semaglutide Prescribed Online Personalized Weight Management Start with a free, no-obligation evaluation only pay if treatment is right for you If prescribed, your subscription includes: Personalized Treatment Plans Medication and Supplies Shipping to Your Door Purchase Options Compounded Oral Semaglutide Prescribed Online Personalized Weight Management Start with a free, no-obligation evaluation only pay if treatment is right for you If prescribed, your subscription includes: Personalized Treatment Plans Medication and Supplies Shipping to Your Door Purchase Options Compounded oral semaglutide is a once-daily GLP-1 medication available as a dissolving tablet or sublingual drops placed under your tongue

The medication mimics your natural GLP-1 peptide hormone, making you feel satisfied after a meal and have fewer cravings
How Tirzepatide Works Tirzepatide's dual agonism creates synergistic metabolic effects: GIP receptor activation enhances insulin secretion and may improve fat metabolism GLP-1 receptor activation suppresses glucagon, slows gastric emptying, and reduces appetite Combined pathway stimulation produces greater metabolic benefits than single-pathway agonists Dose-dependent effects allow for personalized titration based on individual response The dual mechanism explains why tirzepatide has demonstrated superior weight loss outcomes compared to single GLP-1 agonists in head-to-head clinical trials